Results 41 to 50 of about 643,956 (165)

Brain Tumors in Children [PDF]

open access: yesArchives of Neurology, 1995
Brain tumors are the most common form of solid neoplasm of childhood. Progress in the treatment of childhood brain tumors has been frustratingly slow, especially in comparison with other pediatric malignancies. The biology of primary pediatric brain tumors of childhood is just being unraveled.
openaire   +4 more sources

A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1

open access: yesScientific Reports, 2022
Forkhead Box M1 (FOXM1) is known to regulate cell proliferation, apoptosis and tumorigenesis. The lignan, (−)-(2R,3R)-1,4-O-diferuloylsecoisolariciresinol (DFS), from Alnus japonica has shown anti-cancer effects against colon cancer cells by suppressing ...
Jin-Kyoung Shim   +15 more
doaj   +1 more source

Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles

open access: yesPharmaceutics, 2020
Alternative routes of administration are one approach that could be used to bypass the blood−brain barrier (BBB) for effective drug delivery to the central nervous system (CNS). Here, we focused on intranasal delivery of polymer nanoparticles.
Eugene P. Chung   +5 more
doaj   +1 more source

Optimized culturing yields high success rates and preserves molecular heterogeneity, enabling personalized screening for high-grade gliomas

open access: yesnpj Precision Oncology
To discover new treatment options for high-grade glioma (HGG), robust in vitro models are essential, but reliably establishing patient-derived cell cultures remains challenging. We established glioma stem-like cell (GSC) cultures from 114 consecutive HGG
Cassandra Posthoorn-Verheul   +15 more
doaj   +1 more source

Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells

open access: yesMolecular Therapy: Methods & Clinical Development
The COVID-19 pandemic has caused about seven million deaths worldwide. Preventative vaccines have been developed including Spike gp mRNA-based vaccines that provide protection to immunocompetent patients. However, patients with primary immunodeficiencies,
Elizabeth Ogando-Rivas   +11 more
doaj   +1 more source

From Patient-Specific Mathematical Neuro-Oncology to Precision Medicine

open access: yesFrontiers in Oncology, 2013
Gliomas are notoriously aggressive, malignant brain tumors that have variable response to treatment. These patients often have poor prognosis, informed primarily by histopathology.
Anne eBaldock   +20 more
doaj   +1 more source

HYDATID TUMORS OF THE BRAIN. [PDF]

open access: yesJournal of the American Medical Association, 1885
Sir: —Allow me to call attention to two points in the paper by Dr. R. Harvey Reed, on "Hydatid Tumor of the Brain," published in theJournalof July 4th. (1) The term hydatid tumor should be, and usually is, limited to the echinococcus cyst, the larvae of the Taenia echinococcus or Hydatid tapeworm.
openaire   +2 more sources

The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity

open access: yesMolecular Therapy: Oncolytics, 2017
The conditionally replicating oncolytic adenovirus Delta24-RGD (Ad) is currently under investigation in clinical trials for glioblastoma, including in combination with temozolomide (TMZ), the standard chemotherapy for this tumor.
Anne Kleijn   +11 more
doaj   +1 more source

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

open access: yesJournal of Immunology Research, 2017
Although cancer immunotherapy has shown significant promise in mediating efficacious responses, it remains encumbered by tumor heterogeneity, loss of tumor-specific antigen targets, and the regulatory milieu both regionally and systemically.
Elias J. Sayour, Duane A. Mitchell
doaj   +1 more source

Tumor infiltrating lymphocytes in glioblastoma: immunobiology and translational implications

open access: yesnpj Precision Oncology
Glioblastoma (GBM) poses unique challenges to immunotherapy, owing to its low tumor mutational burden, profound antigenic heterogeneity, and highly immunosuppressive microenvironment.
Cameron M. Hill   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy